List of Excipients in API labetalol hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing labetalol hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | LABETALOL HCL IN SODIUM CHLORIDE | labetalol hydrochloride | 0143-9363 | ANHYDROUS DEXTROSE | |
| Hikma Pharmaceuticals USA Inc | LABETALOL HCL IN SODIUM CHLORIDE | labetalol hydrochloride | 0143-9363 | CITRIC ACID MONOHYDRATE | |
| Hikma Pharmaceuticals USA Inc | LABETALOL HCL IN SODIUM CHLORIDE | labetalol hydrochloride | 0143-9363 | EDETATE DISODIUM | |
| Hikma Pharmaceuticals USA Inc | LABETALOL HCL IN SODIUM CHLORIDE | labetalol hydrochloride | 0143-9363 | SODIUM CHLORIDE | |
| Hikma Pharmaceuticals USA Inc | LABETALOL HCL IN SODIUM CHLORIDE | labetalol hydrochloride | 0143-9363 | SODIUM HYDROXIDE | |
| Hikma Pharmaceuticals USA Inc | LABETALOL HYDROCHLORIDE | labetalol hydrochloride | 0641-6252 | ANHYDROUS DEXTROSE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing labetalol hydrochloride
Detailed excipient profiles for labetalol hydrochloride
Excipient focus: ALUMINUM OXIDE
labetalol hydrochloride drug variants containing ALUMINUM OXIDE
labetalol hydrochloride drug variants not containing ALUMINUM OXIDE
Excipient focus: ANHYDROUS CITRIC ACID
labetalol hydrochloride drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Akorn | labetalol hydrochloride | 17478-420 |
| Baxter Healthcare Corporation | labetalol hydrochloride | 36000-320 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS DEXTROSE
labetalol hydrochloride drug variants containing ANHYDROUS DEXTROSE
labetalol hydrochloride drug variants not containing ANHYDROUS DEXTROSE
Excipient focus: ANHYDROUS LACTOSE
labetalol hydrochloride drug variants containing ANHYDROUS LACTOSE
labetalol hydrochloride drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CARNAUBA WAX
labetalol hydrochloride drug variants containing CARNAUBA WAX
labetalol hydrochloride drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
labetalol hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
labetalol hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CITRIC ACID MONOHYDRATE
labetalol hydrochloride drug variants containing CITRIC ACID MONOHYDRATE
labetalol hydrochloride drug variants not containing CITRIC ACID MONOHYDRATE
Excipient focus: COLLOIDAL SILICON DIOXIDE
labetalol hydrochloride drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | labetalol hydrochloride | 16590-994 |
| Rebel Distributors Corp | labetalol hydrochloride | 21695-592 |
| Rebel Distributors Corp | labetalol hydrochloride | 21695-994 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
labetalol hydrochloride drug variants containing CROSPOVIDONE
labetalol hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
labetalol hydrochloride drug variants containing D&C YELLOW NO. 10
labetalol hydrochloride drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
labetalol hydrochloride drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Major Pharmaceuticals | labetalol hydrochloride | 0904-7109 |
| Cardinal Health 107 LLC | labetalol hydrochloride | 55154-8192 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: EDETATE DISODIUM
labetalol hydrochloride drug variants containing EDETATE DISODIUM
labetalol hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: FD&C BLUE NO. 2
labetalol hydrochloride drug variants containing FD&C BLUE NO. 2
labetalol hydrochloride drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C YELLOW NO. 6
labetalol hydrochloride drug variants containing FD&C YELLOW NO. 6
labetalol hydrochloride drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
labetalol hydrochloride drug variants containing FERRIC OXIDE RED
labetalol hydrochloride drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
labetalol hydrochloride drug variants containing FERRIC OXIDE YELLOW
labetalol hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYPROMELLOSE
labetalol hydrochloride drug variants containing HYPROMELLOSE
labetalol hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
labetalol hydrochloride drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | labetalol hydrochloride | 0615-4539 |
| Major Pharmaceuticals | labetalol hydrochloride | 0904-5928 |
| Cardinal Health | labetalol hydrochloride | 55154-6877 |
| Prometheus Laboratories Inc | labetalol hydrochloride | 65483-391 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
labetalol hydrochloride drug variants containing HYPROMELLOSE 2910
labetalol hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
labetalol hydrochloride drug variants containing HYPROMELLOSES
labetalol hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
labetalol hydrochloride drug variants containing LACTOSE
labetalol hydrochloride drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
labetalol hydrochloride drug variants containing LACTOSE MONOHYDRATE
labetalol hydrochloride drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
labetalol hydrochloride drug variants containing MAGNESIUM STEARATE
labetalol hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: METHYLPARABEN
labetalol hydrochloride drug variants containing METHYLPARABEN
labetalol hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: POLYDEXTROSE
labetalol hydrochloride drug variants containing POLYDEXTROSE
labetalol hydrochloride drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOL
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOL 3350
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOL 400
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 4000
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| Epic Pharma LLC | labetalol hydrochloride | 42806-327 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 4000
Excipient focus: POLYETHYLENE GLYCOL 6000
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOL 6000
| Company | Ingredient | NDC |
|---|---|---|
| Cadila Pharmaceuticals Limited | labetalol hydrochloride | 71209-083 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOLS
labetalol hydrochloride drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| NCS HealthCare of KY Inc dba Vangard Labs | labetalol hydrochloride | 0615-7686 |
| Dispensing Solutions Inc | labetalol hydrochloride | 68258-6047 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
labetalol hydrochloride drug variants containing POLYSORBATE 80
labetalol hydrochloride drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
labetalol hydrochloride drug variants containing POLYVINYL ALCOHOL
labetalol hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: PROPYLPARABEN
labetalol hydrochloride drug variants containing PROPYLPARABEN
labetalol hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SILICON DIOXIDE
labetalol hydrochloride drug variants containing SILICON DIOXIDE
labetalol hydrochloride drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CHLORIDE
labetalol hydrochloride drug variants containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | labetalol hydrochloride | 0143-9363 |
| >Company | >Ingredient | >NDC |
labetalol hydrochloride drug variants not containing SODIUM CHLORIDE
Excipient focus: SODIUM HYDROXIDE
labetalol hydrochloride drug variants containing SODIUM HYDROXIDE
labetalol hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
labetalol hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A
labetalol hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN
labetalol hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A CORN
labetalol hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
labetalol hydrochloride drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
labetalol hydrochloride drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
labetalol hydrochloride drug variants containing STARCH, CORN
labetalol hydrochloride drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
labetalol hydrochloride drug variants containing STARCH, PREGELATINIZED CORN
labetalol hydrochloride drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: TALC
labetalol hydrochloride drug variants containing TALC
labetalol hydrochloride drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
labetalol hydrochloride drug variants containing TITANIUM DIOXIDE
labetalol hydrochloride drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
labetalol hydrochloride drug variants containing TRIACETIN
labetalol hydrochloride drug variants not containing TRIACETIN
Excipient focus: WATER
labetalol hydrochloride drug variants containing WATER
labetalol hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
